Skip to content
10-Q

Quarterly Report

Longboard Pharmaceuticals, Inc.

0000950170-24-123341

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 5, 2024 39.05M sh
Shares Diluted Q3 2024 · Sep 30, 2024 38.96M sh
Shares Diluted Q3 2024 · Sep 30, 2024 37.72M sh
Shares Diluted Q3 2024 · Sep 30, 2023 23.49M sh
Shares Diluted Q3 2024 · Sep 30, 2023 22.3M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$54.9M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$39.84M
Short Term Investments Q3 2024 · Sep 30, 2024 $260.84M
Short Term Investments Q3 2024 · Dec 31, 2023 $34.17M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $27.61M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $14.33M
Stockholders Equity Q3 2024 · Sep 30, 2024 $275.19M
Stockholders Equity Q3 2024 · Jun 30, 2024 $294.6M
Stockholders Equity Q3 2024 · Mar 31, 2024 $313.71M
Stockholders Equity Q3 2024 · Dec 31, 2023 $40.92M
Stockholders Equity Q3 2024 · Sep 30, 2023 $52.04M
Stockholders Equity Q3 2024 · Jun 30, 2023 $58.11M
Stockholders Equity Q3 2024 · Mar 31, 2023 $72.13M
Stockholders Equity Q3 2024 · Dec 31, 2022 $61.47M
Current Liabilities Q3 2024 · Sep 30, 2024 $18.35M
Current Liabilities Q3 2024 · Dec 31, 2023 $9.77M
Current Assets Q3 2024 · Sep 30, 2024 $293.03M
Current Assets Q3 2024 · Dec 31, 2023 $50.22M
Total Assets Q3 2024 · Sep 30, 2024 $297.01M
Total Assets Q3 2024 · Dec 31, 2023 $50.7M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.63
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.63
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.55
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.77
Eps Basic Q3 2024 · Sep 30, 2024 −$0.63
Eps Basic Q3 2024 · Sep 30, 2024 −$1.63
Eps Basic Q3 2024 · Sep 30, 2023 −$0.55
Eps Basic Q3 2024 · Sep 30, 2023 −$1.77
Sga Expense Q3 2024 · Sep 30, 2024 $6.67M
Sga Expense Q3 2024 · Sep 30, 2024 $16.81M
Sga Expense Q3 2024 · Sep 30, 2023 $3.09M
Sga Expense Q3 2024 · Sep 30, 2023 $9.63M
Rd Expense Q3 2024 · Sep 30, 2024 $21.45M
Rd Expense Q3 2024 · Sep 30, 2024 $55.07M
Rd Expense Q3 2024 · Sep 30, 2023 $10.49M
Rd Expense Q3 2024 · Sep 30, 2023 $31.55M
Net Income Q3 2024 · Sep 30, 2024 −$24.54M
Net Income Q3 2024 · Sep 30, 2024 −$61.31M
Net Income Q3 2024 · Jun 30, 2024 −$21.79M
Net Income Q3 2024 · Mar 31, 2024 −$14.99M
Net Income Q3 2024 · Sep 30, 2023 −$12.93M
Net Income Q3 2024 · Sep 30, 2023 −$39.39M
Net Income Q3 2024 · Jun 30, 2023 −$15M
Net Income Q3 2024 · Mar 31, 2023 −$11.46M
Operating Income Q3 2024 · Sep 30, 2024 −$28.12M
Operating Income Q3 2024 · Sep 30, 2024 −$71.88M
Operating Income Q3 2024 · Sep 30, 2023 −$13.58M
Operating Income Q3 2024 · Sep 30, 2023 −$41.19M